![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Ito Hiroaki
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.8, Iss.4, 2004-08, pp. : 287-294
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapy of Crohn’s disease in childhood
By Beattie R Mark Bremner A Ronald F
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-IL-12/23 in Crohn's Disease: Bench and Bedside
Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. :